Background/Aim: Little information is available about the association between peripheral T-lymphocyte
expression of programmed cell death protein 1 (PD1) and the efficacy of immune …

Immune checkpoint inhibitors have significantly improved the prognosis in patients with non-small
cell lung cancer, compared with cytotoxic agents. However, the prediction of treatment …

Background Physical activity (PA) is considered as one of the most important prognostic
predictors in chronic obstructive pulmonary disease (COPD) patients. Longevity gene, SIRT1, is …

Abstract Treatment with epidermal growth factor receptor‑tyrosine kinase inhibitors (EGFR‑TKIs)
has been shown to prolong survival in patients with EGFR mutation‑positive non‑small …

We explored the associations between progression-free survival (PFS) after the initiation of
PD-1 inhibitor therapy and the clinical parameters in patients with NSCLC. We reviewed the …

Determination of the presence of epidermal growth factor receptor (EGFR) gene mutation is
useful for predicting the efficacy of gefitinib. However, the survival rate following the initiation …

Conflicting findings have been reported regarding the role of adiponectin in asthma. The aim
of this study was to evaluate the association of adiponectin with pulmonary functions and …

Background: Among patients with non-small cell lung cancer (NSCLC), we compared the
progression-free survival (PFS) and proportion of acquisition of T790M mutation of the …

Aims and Background It is reported that about 20% of patients with small cell lung cancer (SCLC)
receive third-line chemotherapy. We conducted a retrospective study to investigate the …

Objective Studies have suggested the potential efficacy of immune checkpoint inhibitors (ICIs)
for pulmonary sarcomatoid carcinoma. This multicenter observational study was …